UB Paderborn / Katalog / Suche / in CDI

Impact of Multivessel Coronary Artery Disease and Noninfarct-Related Artery Revascularization on Outcome of Patients With ST-Elevation Myocardial Infarction Transferred for Primary Percutaneous Coronary Intervention (from the EUROTRANSFER Registry)

The American journal of cardiology, 2010-08, Vol.106 (3), p.342-347

2010

Volltextzugriff (PDF)

Practice setting and secondary prevention of coronary artery disease

Archives of medical science, 2018-08, Vol.14 (5), p.979-987

2018

Volltextzugriff (PDF)

Impact of direct stenting on outcome of patients with ST-elevation myocardial infarction transferred for primary percutaneous coronary intervention (from the EUROTRANSFER registry)

Catheterization and cardiovascular interventions, 2014-11, Vol.84 (6), p.925-931

2014

Volltextzugriff (PDF)

Impact of smoking status on outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention

Journal of thrombosis and thrombolysis, 2012-10, Vol.34 (3), p.397-403

2012

Volltextzugriff (PDF)

Asymmetric dimethylarginine predicts decline of glucose tolerance in men with stable coronary artery disease: a 4.5-year follow-up study

Cardiovascular diabetology, 2013-04, Vol.12 (1), p.64-64

2013

Volltextzugriff (PDF)

Out-of-hospital cardiac arrest in patients treated with primary PCI for STEMI. Long-term follow up data from EUROTRANSFER registry

Resuscitation, 2012-03, Vol.83 (3), p.303-306

2012

Volltextzugriff (PDF)

Age-related differences in treatment strategies and clinical outcomes in unselected cohort of patients with ST-segment elevation myocardial infarction transferred for primary angioplasty

Journal of thrombosis and thrombolysis, 2012-08, Vol.34 (2), p.214-221

2012

Volltextzugriff (PDF)

Early abciximab administration before transfer for primary percutaneous coronary interventions for ST-elevation myocardial infarction reduces 1-year mortality in patients with high-risk profile. Results from EUROTRANSFER Registry

The American heart journal, 2009-10, Vol.158 (4), p.569-575

2009

Volltextzugriff (PDF)

Admission glucose level and in-hospital outcomes in diabetic and non-diabetic patients with acute myocardial infarction

Clinical research in cardiology, 2010-11, Vol.99 (11), p.715-721

2010

Volltextzugriff (PDF)

Chronic heart failure management in primary healthcare in Poland: Results of a nationwide cross-sectional study

The European journal of general practice, 2018-01, Vol.24 (1), p.1-8

2018

Volltextzugriff (PDF)

Early abciximab administration before primary percutaneous coronary intervention improves infarct-related artery patency and left ventricular function in high-risk patients with anterior wall myocardial infarction: A randomized study

The American heart journal, 2007-03, Vol.153 (3), p.360-365

2007

Volltextzugriff (PDF)

Quality of care of hospitalised patients with heart failure in Poland in 2013: results of the second nationwide survey

Kardiologia polska, 2017-01, Vol.75 (6), p.527-534

2017

Volltextzugriff (PDF)

Early administration of abciximab reduces mortality in female patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the EUROTRANSFER Registry)

Journal of thrombosis and thrombolysis, 2013-10, Vol.36 (3), p.240-246

2013

Volltextzugriff (PDF)

The costs of heart failure in Poland from the public payer's perspective. Polish programme assessing diagnostic procedures, treatment and costs in patients with heart failure in randomly selected outpatient clinics and hospitals at different levels of care: POLKARD

Kardiologia polska, 2013, Vol.71 (3), p.224

2013

Volltextzugriff (PDF)

Polish Registry of Acute Coronary Syndromes (PL-ACS). Characteristics, treatments and outcomes of patients with acute coronary syndromes in Poland

Kardiologia polska (1957), 2007-08, Vol.65 (8), p.861-72; discussion 873-4

2007

Volltextzugriff (PDF)

Separate dosing of clopidogrel and omeprazole may improve platelet inhibition on dual antiplatelet therapy

International journal of cardiology, 2011-05, Vol.149 (1), p.124-125

2011

Volltextzugriff (PDF)

Early abciximab administration before primary percutaneous coronary intervention improves clinical outcome in diabetic patients with ST-segment elevation myocardial infarction (EUROTRANSFER Registry)

Atherosclerosis, 2012-07, Vol.223 (1), p.212-218

2012

Volltextzugriff (PDF)

Inverted takotsubo cardiomyopathy in a patient with essential thrombocythemia exposed to anagrelide and phentermine

International journal of cardiology, 2012-10, Vol.160 (2), p.e31-e32

2012

Volltextzugriff (PDF)

Predictive utility of NT-pro BNP for infarct size and left ventricle function after acute myocardial infarction in long-term follow-up

Disease markers, 2013-01, Vol.34 (3), p.199-204

2013

Volltextzugriff (PDF)

Introduction of new oral antiplatelet drugs in myocardial infarction hospital network: initial experience

Journal of thrombosis and thrombolysis, 2014-04, Vol.37 (3), p.243-245

2014

Volltextzugriff (PDF)

One-year observation of inflammatory markers in patients with aortic valve stenosis

The Journal of heart valve disease, 2011-11, Vol.20 (6), p.639

2011

Volltextzugriff (PDF)

Enhanced oxidative stress in hypertrophic cardiomyopathy

Pharmacological reports, 2009-05, Vol.61 (3), p.491-495

2009

Volltextzugriff (PDF)

Reduced Urinary Excretion of Nitric Oxide Metabolites and Increased Plasma Levels of Asymmetric Dimethylarginine in Men with Essential Hypertension

Journal of cardiovascular pharmacology, 1999-04, Vol.33 (4), p.652-658

1999

Volltextzugriff (PDF)

One-year observation of inflammatory markers in patients with aortic valve stenosis who expressed high or low Chlamydia pneumoniae antibody titers

The Journal of heart valve disease, 2012-09, Vol.21 (5), p.599

2012

Volltextzugriff (PDF)

Transradial approach in patients with ST-elevation myocardial infarction treated with abciximab results in fewer bleeding complications: data from EUROTRANSFER registry

Coronary artery disease, 2010-08, Vol.21 (5), p.292-297

2010

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Impact of Multivessel Coronary Artery Disease and Noninfarct-Related Artery Revascularization on Outcome of Patients With ST-Elevation Myocardial Infarction Transferred for Primary Percutaneous Coronary Intervention (from the EUROTRANSFER Registry)

Practice setting and secondary prevention of coronary artery disease

Impact of direct stenting on outcome of patients with ST-elevation myocardial infarction transferred for primary percutaneous coronary intervention (from the EUROTRANSFER registry)

Impact of smoking status on outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention

Asymmetric dimethylarginine predicts decline of glucose tolerance in men with stable coronary artery disease: a 4.5-year follow-up study

Out-of-hospital cardiac arrest in patients treated with primary PCI for STEMI. Long-term follow up data from EUROTRANSFER registry

Age-related differences in treatment strategies and clinical outcomes in unselected cohort of patients with ST-segment elevation myocardial infarction transferred for primary angioplasty

Early abciximab administration before transfer for primary percutaneous coronary interventions for ST-elevation myocardial infarction reduces 1-year mortality in patients with high-risk profile. Results from EUROTRANSFER Registry

Admission glucose level and in-hospital outcomes in diabetic and non-diabetic patients with acute myocardial infarction

Chronic heart failure management in primary healthcare in Poland: Results of a nationwide cross-sectional study

Early abciximab administration before primary percutaneous coronary intervention improves infarct-related artery patency and left ventricular function in high-risk patients with anterior wall myocardial infarction: A randomized study

Quality of care of hospitalised patients with heart failure in Poland in 2013: results of the second nationwide survey

Early administration of abciximab reduces mortality in female patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the EUROTRANSFER Registry)

The costs of heart failure in Poland from the public payer's perspective. Polish programme assessing diagnostic procedures, treatment and costs in patients with heart failure in randomly selected outpatient clinics and hospitals at different levels of care: POLKARD

Polish Registry of Acute Coronary Syndromes (PL-ACS). Characteristics, treatments and outcomes of patients with acute coronary syndromes in Poland

Separate dosing of clopidogrel and omeprazole may improve platelet inhibition on dual antiplatelet therapy

Early abciximab administration before primary percutaneous coronary intervention improves clinical outcome in diabetic patients with ST-segment elevation myocardial infarction (EUROTRANSFER Registry)

Inverted takotsubo cardiomyopathy in a patient with essential thrombocythemia exposed to anagrelide and phentermine

Predictive utility of NT-pro BNP for infarct size and left ventricle function after acute myocardial infarction in long-term follow-up

Introduction of new oral antiplatelet drugs in myocardial infarction hospital network: initial experience

One-year observation of inflammatory markers in patients with aortic valve stenosis

Enhanced oxidative stress in hypertrophic cardiomyopathy

Reduced Urinary Excretion of Nitric Oxide Metabolites and Increased Plasma Levels of Asymmetric Dimethylarginine in Men with Essential Hypertension

One-year observation of inflammatory markers in patients with aortic valve stenosis who expressed high or low Chlamydia pneumoniae antibody titers

Transradial approach in patients with ST-elevation myocardial infarction treated with abciximab results in fewer bleeding complications: data from EUROTRANSFER registry

Suchergebnisse filtern